Table 2.
Patient Demographics | |||
---|---|---|---|
Control | Intervention | P Value | |
Gender | Male – 54% Female – 46% |
Male – 59% Female – 41% |
0.66 |
Income Level | ≤ 50K – 74% > 50K – 26% |
≤ 50K – 83% > 50K – 17% |
0.37 |
Insurance Coverage | Medicare – 37% Medicare + Medicaid – 3% Medicare + Private – 43% Medicare + Private – 17% |
Medicare – 38% Medicare + Medicaid – 5% Medicare + Private – 41% Medicare + Private – 16% |
0.96 |
Race | Caucasian – 97% Other – 3% |
Caucasian – 91% Other – 9% |
0.36 |
Education Level | ≤ High School – 60% > High School – 40% |
≤ High School – 57% > High School – 43% |
0.96 |
Marital Status | Married – 65% Other – 35% |
Married – 57% Other – 43% |
0.63 |
Tumor type | GI – 38% Lung – 47% GU – 15% Other – 0% |
GI – 48% Lung – 37% GU – 8% Other – 5% |
0.16 |
Tumor Stage | III – 32% IV – 68% |
III – 27% IV – 72% |
0.80 |
Line of therapy | First – 94% Second – 6% |
First – 95% Second -5% |
1.00 |
Baseline Geriatric Assessment Results | |||
Control | Intervention | P value | |
Activities of Daily Living (ADL) impairment | 20% | 27% | 0.48 |
Instrumental Activities of Daily Living (IADL) impairment | 31% | 59% | 0.02 |
≥3 Comorbidities | 29% | 41% | 0.29 |
Physical Activity Impairment | 60% | 65% | 0.67 |
Geriatric Depression Screen >5 | 12% | 19% | 0.52 |
Vision Impairment (self-report fair or worse) | 14% | 8% | 0.47 |
Hearing Impairment (self-report fair or worse) | 29% | 19% | 0.34 |
History of Falls | 23% | 27% | 0.77 |
Self-rated Karnofsky Performance Status <70 | 14% | 22% | 0.32 |
Short Physical Performance Battery <9 | 69% | 73% | 0.68 |
Abnormal Mini-Cog score | 19% | 33% | 0.12 |
Blessed Orientation-Memory-Concentration Test score >10 | 6% | 3% | 0.61 |
Baseline Cancer and Aging Research Group (CARG) Toxicity Score | Low-9% Medium-76% High-15% |
Low-19% Medium-46% High-35% |
0.04 |